PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Oxycodone with naloxone - Restless Leg Syndrome

PAD Profile : Oxycodone with naloxone - Restless Leg Syndrome

Brand Names Include :
Targinact, Myloxifin

Traffic Light Status

Status 1 of 1.

Status :
Non Formulary
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
22 January 2018
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Prescribing Clinical Network does not recommend the use of oxycodone and naloxone combination product
Oxycodone and Naloxone Combination Product will be considered BLACK on the traffic light system, prescribers should:
o NOT initiate oxycodone and naloxone combination product for any new patient
AND
o De-prescribe oxycodone and naloxone combination product, with specialist support if appropriate, in all patients
In exceptional circumstances where there is a clinical need for oxycodone and naloxone combination product to be prescribed in primary care this should be undertaken in a cooperation arrangement with a multidisciplinary team and / or other healthcare professional

Associated BNF Codes

04. Central Nervous System
04.07.02. Opioid analgesics
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More